Iovance Biotherapeutics, Inc. (IOVA): Proyeksi bathi mangsa ngarep

Logo perusahaan publik Iovance (IOVA)

Iovance Biotherapeutics (IOVA) holds a monopoly on TIL therapy for melanoma, providing the company with significant pricing power. The company's projected profit levels confirm this potential, with the metric holding around . Risks are tied to the creation of complex logistics for product commercialization, although management is successfully deploying a network of specialized centers following FDA approval.

IOVA - Bathi resik sing dikarepake iovance.com ing rentang 04.07.2022 - 18.11.2026

IOVA (Iovance Corp): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:IOVA, Iovance Biotherapeutics Inc
Produk dadi Iovance

This indicator reflects the market consensus regarding future cash flows, measuring investor optimism through the discounting of expected earnings. By analyzing the level of priced-in profits, one can see how the monopoly status of Amtagvi and the complexity of TIL therapy production transform the technological advantage of Iovance Biotherapeutics (IOVA) into concrete financial expectations, determining the long-term fair value of the company's shares.

Analisis perusahaan pesaing

Bathi sing dikarepake NantKwest|Bathi resik sing dikarepake Immunocore IMCR|Proyeksi bathi mangsa ngarep JANX|Arcus Biosciences, Inc. (RCUS) - Proyeksi bathi resik|Zymeworks Inc - Bathi mangsa ngarep|Tango Therapeutics, Inc. (TNGX) - Bathi resik sing dikarepake|IMTX: Bathi mangsa ngarep|Penghasilan resik sing dikarepake XNCR (Xencor)|CMPX: Proyeksi bathi mangsa ngarep|REPL - Prakiraan bathi perusahaan|Bathi sing dikarepake lyell.com|Bathi mangsa ngarep innate-pharma.com (IPHA)|Bathi sing dikarepake Pyxis Oncology Inc. (PYXS)|Bathi mangsa ngarep Compugen Limited CGEN|IO Biotech Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Sutro Biopharma, Inc STRO|INKT - Bathi sing dikarepake|HOWL (Werewolf Therapeutics, Inc.) - Prakiraan bathi resik|immixbio.com (IMMX) - Bathi sing dikarepake|Bathi resik sing dikarepake ALX Oncology Holdings (ALXO)|Bathi mangsa ngarep CUE|PDSB - Proyeksi bathi resik|Bathi mangsa ngarep SONN (Sonnet BioTherapeutics)|Bathi resik mangsa ngarep MAIA|Proyeksi bathi mangsa ngarep LIMN (Liminatus Pharma LLC)|Penghasilan resik sing dikarepake LVTX|nextcure.com - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Leap Therapeutics|Intensity Tx (INTS) - Bathi sing dikarepake|Sensei Biotherapeutics Inc - Penghasilan resik sing dikarepake|TOVX (therivabio.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep gritstonebio.com|Bathi sing dikarepake Kineta Inc (KA)|NEXI: Bathi forward|Turnstone Biologics Corp. - Bathi mangsa ngarep|Vaccinex (VCNX) - Bathi resik sing dikarepake|Harpoon Therapeutics, Inc. - Proyeksi bathi mangsa ngarep